Viking Therapeutics, Inc. 4
4 · Viking Therapeutics, Inc. · Filed May 5, 2017
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Tax Payment
Common Stock, par value $0.00001 per share
2017-05-04$1.34/sh−8,192$10,977→ 80,604 total
Footnotes (2)
- [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock.
- [F2]Includes 147 shares acquired on May 20, 2015 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, 2,643 shares acquired on November 20, 2015 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, 5,694 shares acquired on May 20, 2016 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, and 2,908 shares acquired on November 18, 2016 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.